<?xml version="1.0" encoding="UTF-8"?>
<p>As for previous attempts in vaccine preclinical experimentation to SARS-CoV, virus studies are needed to ascertain the most suitable animal models, especially electing small animals that closely resemble the clinical disease caused by SARS-CoV2 infection in humans and its etiopathogenetic mechanisms [
 <xref rid="B16-ijms-21-05145" ref-type="bibr">16</xref>]. These are at low cost and of easy manipulation, and they would present receptor affinity for the virus and generate specific immune responses and protection [
 <xref rid="B16-ijms-21-05145" ref-type="bibr">16</xref>].
</p>
